daratumumab
janssen
['leusm', 'lymphoma', 'delphinus']
congress #asco22 | laura hogan reports on the delphinus phase ii study of dara +vlpd in pediatric (p) &amp; ya pts with r/r t-all or lymphoblastic lymphoma. n=24. orr was 83.3% in p-, 60.0% in ya-all &amp; 50.0% in ll pts. 41.7% p-all pts achieved mrd negativity #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm